AlzeCure Pharma AB (publ) (FRA:AC6)
Germany flag Germany · Delayed Price · Currency is EUR
0.1520
0.00 (0.00%)
Last updated: Jan 28, 2026, 8:15 AM CET

AlzeCure Pharma AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
59.1931.529.125.5841.74112.43
Cash & Short-Term Investments
59.1931.529.125.5841.74112.43
Cash Growth
51.04%8.24%13.77%-38.73%-62.88%-38.39%
Accounts Receivable
-0.04---0.01
Other Receivables
2.041.741.471.381.542.35
Receivables
2.041.771.471.381.542.36
Prepaid Expenses
0.980.941.040.550.920.37
Other Current Assets
-----0.7
Total Current Assets
62.2134.2131.6127.5144.2115.86
Property, Plant & Equipment
4.370.210.380.851.421.94
Other Intangible Assets
0.020.020.020.020.020.02
Other Long-Term Assets
---42.460.010.01
Total Assets
66.5934.443270.8445.65117.83
Accounts Payable
3.362.692.694.855.973.97
Accrued Expenses
7.055.254.955.186.382.91
Other Current Liabilities
2.680.310.590.330.320.2
Total Current Liabilities
13.098.258.2310.3512.677.07
Total Liabilities
15.938.258.2310.3512.677.07
Common Stock
2.872.211.551.270.940.94
Additional Paid-In Capital
453.27399.43362.44361.98278.84278.84
Retained Earnings
-405.48-375.45-340.22-303.05-246.81-169.03
Comprehensive Income & Other
---0.28--
Shareholders' Equity
50.6626.1923.7760.4832.97110.76
Total Liabilities & Equity
66.5934.443270.8445.65117.83
Net Cash (Debt)
56.3631.529.125.5841.74112.43
Net Cash Growth
43.81%8.24%13.77%-38.73%-62.88%-38.39%
Net Cash Per Share
0.600.410.470.541.112.98
Filing Date Shares Outstanding
114.9188.362.0962.0937.7737.77
Total Common Shares Outstanding
114.9188.362.0962.0937.7737.77
Working Capital
49.1225.9623.3817.1531.53108.79
Book Value Per Share
0.440.300.380.970.872.93
Tangible Book Value
50.6526.1723.7660.4732.96110.74
Tangible Book Value Per Share
0.440.300.380.970.872.93
Machinery
-3.022.92.92.92.84
Source: S&P Global Market Intelligence. Standard template. Financial Sources.